🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Haemonetics Corporation

HAE Healthcare
$72.78 +$0.25 (0.34%)
Market Cap: $3.31 B
Gurus Holding
7
Popularity Rank
#1223
% of Shares Held
8.00%
Net Activity (Q1 2026)
-$30.41 M

Guru Ownership Trend

Guru Analysis for Haemonetics Corporation (HAE)

Haemonetics Corporation (HAE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $264.61 M.

Top institutional holders include Cliff Asness and Chuck Royce.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $30.41 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 159.6%. Conversely, Steven Cohen reduced exposure by 93.3%.

Key Holders

Top 5 by Value

$185.68 M
$4.03 M
$3.21 M
$2.75 M
$2.73 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$18.15 M
Total Buy Value
New Buys 3
Additions 2
-$48.56 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
5

FAQs for Haemonetics Corporation (HAE)

Major holders include Cliff Asness ($185.68 M), Chuck Royce ($4.03 M), Steven Cohen ($3.21 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 3.64 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $30.41 M, with 5 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited HAE. The total reported sell value was $48.56 M.

Yes, 3 managers opened new positions in HAE, and 2 increased their existing holdings. The total reported buy value was $18.15 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.09% Add 6.1% 3,356,543 $185.68 M Q1 2026
0.04% 71,475 $4.03 M Q1 2026
0.00% Reduce -93.3% 56,868 $3.21 M Q1 2026
0.01% Add 159.6% 48,842 $2.75 M Q1 2026
0.01% New Buy 48,377 $2.73 M Q1 2026
0.00% New Buy 43,200 $2.43 M Q1 2026
0.13% New Buy 10,500 $591,780 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form